Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Preserving Access to Life-Saving Medications Act of 2011
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
H.R. 2245, S. 296, "Preserving Access to Life-Saving Medications Act," all provisions and H.R. 3839, "Drug Shortage Prevention Act of 2012." Support for S.1584, "The Drug Safety and Accountability Act," a bill to ensure drug supply safety and give FDA mandatory recall authoirty. Contact concerning Food and Drug Administartion (FDA) authority to manage drug shortages. Communications to FDA on expansion of over the counter medicines (OTC), barcoding, and off label promotion of prescription drugs. Presentations to the FDA on OTC Expansion and Anthrax Medikits.
Drug Shortage Prevention Act of 2012
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS via AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
2012 · fourth_quarter · Q4
Labor-Health and Human Services Appropriations seeking additional Food and Drug Administration (FDA) funding. Communication to FDA on Rescheduling Hydrocodone containing mediations.
H.R. 6413, support for the "Transitional Care Act of 2012." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communication to FDA on approval of biosimilars and drug safety. Communications to Health Resources and Services Administration on 340B drug discount program. Communication with FDA and Centers for Disease Control and Prevention on compounding.Provided input on H.R. 6584, "Verifying Authority and Legality In Drug Compounding Act of 2012."
Source: Senate LDA
H.R. 2245, S. 296, "Preserving Access to Life-Saving Medications Act," all provisions and H.R. 3839, "Drug Shortage Prevention Act of 2012." Support for S.1584, "The Drug Safety and Accountability Act," a bill to ensure drug supply safety and give FDA mandatory recall authoirty. Contact concerning Food and Drug Administartion (FDA) authority to manage drug shortages. Communications to FDA on expansion of over the counter medicines (OTC), barcoding, and off label promotion of prescription drugs. Presentations to the FDA on OTC Expansion and Anthrax Medikits.
Food and Drug Administration Reform Act of 2012
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
S. 3187, H.R. 5651, Support for the Drug Shortages provisions within the "Food and Drug Administration Safety and Innovation Act." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communications to FDA on approval of biosimilars, drug safety, expansion of over the counter (OTC) medicines. Communications to Health Resources and Services Administration on 340B drug discount program.
Medicare Transitional Care Act of 2012
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
H.R. 6413, support for the "Transitional Care Act of 2012." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communication to FDA on approval of biosimilars and drug safety. Communications to Health Resources and Services Administration on 340B drug discount program. Communication with FDA and Centers for Disease Control and Prevention on compounding.Provided input on H.R. 6584, "Verifying Authority and Legality In Drug Compounding Act of 2012."
Medicare Transitional Care Act of 2012
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
S. 3187, Support for the Drug Shortages provisions within the "Food and Drug Administration Safety and Innovation Act." H.R. 6413, support for the "Transitional Care Act of 2012." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communications to FDA on approval of biosimilars and drug safety. Communications to Health Resources and Services Administration on 340B drug discount program.
Verifying Authority and Legality In Drug Compounding Act of 2012
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
H.R. 6413, support for the "Transitional Care Act of 2012." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communication to FDA on approval of biosimilars and drug safety. Communications to Health Resources and Services Administration on 340B drug discount program. Communication with FDA and Centers for Disease Control and Prevention on compounding.Provided input on H.R. 6584, "Verifying Authority and Legality In Drug Compounding Act of 2012."
Preserving Access to Life-Saving Medications Act of 2011
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
H.R. 2245, S. 296, "Preserving Access to Life-Saving Medications Act," all provisions. Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communications to FDA on dietary supplements, long-acting opiods, Prescription Drug User Fee Act presentation at FDA public meeting. Communications with the National Institute for Occupational Safety and Health (NIOSH) on their proposed list of hazardous drugs for 2012. Support for S. 1584, "The Drug Safety and Accountability Act," a bill to ensure drug supply safety and give FDA mandatory recall authority.
Preserving Access to Life-Saving Medications Act of 2011
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
H.R. 2245, S. 296, "Preserving Access to Life-Saving Medications Act," all provisions. Contacts concerning Food and Drug Admnistration (FDA) authority to manage drug shortages. Communication to FDA on withdrawal of unapproved drugs, presentation at FDA Public Workshop on drug shortages. Labor-Health and Human Services appropriations, fiscal year 2011; support for Administration's request for FDA funding. Contacts concerning funding for section 3503 of the Affordable Care Act (P.L. 111-148)
340B Program Improvement Act
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
Comments to the Health Resources and Services Administration on the 340B Drug Discount Program and the procurement of orphan drugs under the program. Submitted letter of support for H.R. 2674, the 340B Improvement Act of 2011.
Fair Tax Act of 2009
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
H.R. 2245, S. 296, "Preserving Access to Life-Saving Medications Act," all provisions. Contacts concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communication to the FDA on Medication guideline distribution and the REMS program, drug shortages. Labor-Health and Human Services appropriations, fiscal year 2010 and 2011; support for Administration's request for FDA funding. Contacts concerning funding for section 3503 of Affordable Care Act (P.L. 111-148). Communication to the Office of the National Coordinator for Health Information Technology regarding its strategic plan. Communication to Office of Management and Budget concerning consumer medication information.
Fair Tax Act of 2009
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
S. 296, Preserving Access to Life-Saving Medications Act, all provisions. Contacts concerning Food and Drug Admnistration (FDA)authority to manage drug shortages. Communication to Office of the National Coordinator for Health Information Technology regarding meaningful use implementation. Labor-Health and Human Services Appropriations, fiscal year 2010 and 2011; support for Administration's request for FDA funding. Contacts concerning funding for section 3503 of Affordable Care Act (PL 111-148). Communication to repeal IRS form 1099 reporting provision in Affordable Care Act. S. 48, Pharmacist Student Loan Repayment Eligibility Act, all provisions.
Communication with Centers for Medicare and Medicaid Services regarding Innovation Center and direct reimbursement under Medicare program.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS via AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
2012 · third_quarter · Q3
Communication with Centers for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare program, outpatient hospital payment, Part D, and Conditions of Participation regarding single use vials of drugs and drug shortages.
Labor-Health and Human Services Appropriations and asked for additional Food and Drug Administration (FDA) funding. Letter to NIOSH (CDC) on E-health records.
S. 3187, Support for the Drug Shortages provisions within the "Food and Drug Administration Safety and Innovation Act." H.R. 6413, support for the "Transitional Care Act of 2012." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communications to FDA on approval of biosimilars and drug safety. Communications to Health Resources and Services Administration on 340B drug discount program.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS via AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
2012 · second_quarter · Q2
S. 3187, H.R. 5651, Support for the Drug Shortages provisions within the "Food and Drug Administration Safety and Innovation Act." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communications to FDA on approval of biosimilars, drug safety, expansion of over the counter (OTC) medicines. Communications to Health Resources and Services Administration on 340B drug discount program.
Labor-Health and Human Services Appropriations and asked for additional FDA funding.
Communication with Centers for Medicare and Medicaid Services regarding Innovation Center, funding for specialized pharmacy resident programs, direct reimbursement under the Medicare program, inpatient hospital payments, and Electronics Health Records Incentive program.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS via AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
2012 · first_quarter · Q1
Labor-Health and Human Services appropriations and asked for additional FDA funding.
Communication with Centers for Medicare and Medicaid Services regarding Innovation Center, funding for specialized pharmacy resident programs, and direct reimbursement under the Medicare program.
H.R. 2245, S. 296, "Preserving Access to Life-Saving Medications Act," all provisions and H.R. 3839, "Drug Shortage Prevention Act of 2012." Support for S.1584, "The Drug Safety and Accountability Act," a bill to ensure drug supply safety and give FDA mandatory recall authoirty. Contact concerning Food and Drug Administartion (FDA) authority to manage drug shortages. Communications to FDA on expansion of over the counter medicines (OTC), barcoding, and off label promotion of prescription drugs. Presentations to the FDA on OTC Expansion and Anthrax Medikits.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS via AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
2011 · fourth_quarter · Q4
H.R. 2245, S. 296, "Preserving Access to Life-Saving Medications Act," all provisions. Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communications to FDA on dietary supplements, long-acting opiods, Prescription Drug User Fee Act presentation at FDA public meeting. Communications with the National Institute for Occupational Safety and Health (NIOSH) on their proposed list of hazardous drugs for 2012. Support for S. 1584, "The Drug Safety and Accountability Act," a bill to ensure drug supply safety and give FDA mandatory recall authority.
Labor-Health and Human Services appropriations, fiscal year 2011; support for Administration's request for FDA funding. Contacts concerning funding for section 3503 of Affordable Care Act (P.L. 111-148).
Communication with Centers for Medicare and Medicaid Services regarding influenza vaccines, conditions of participation, Innovation Center, funding for specialized pharmacy resident programs, Part D utilization review and direct reimbursement under the Medicare program.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS via AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
2011 · third_quarter · Q3
Communication with Centers for Medicare and Medicaid Services regarding hospital outpatient prospective payment system, influenza vaccines, conditions of participation, Innovation Center, funding for specialized pharmacy residency programs, and direct reimbursement under the Medicare program.
H.R. 2245, S. 296, "Preserving Access to Life-Saving Medications Act," all provisions. Contacts concerning Food and Drug Admnistration (FDA) authority to manage drug shortages. Communication to FDA on withdrawal of unapproved drugs, presentation at FDA Public Workshop on drug shortages. Labor-Health and Human Services appropriations, fiscal year 2011; support for Administration's request for FDA funding. Contacts concerning funding for section 3503 of the Affordable Care Act (P.L. 111-148)
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS via AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
2011 · second_quarter · Q2
Communication with Government Accountability Office concerning its study (required under section 7103, P.L. 111-148) on improving the 340B drug discount program.
H.R. 2245, S. 296, "Preserving Access to Life-Saving Medications Act," all provisions. Contacts concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communication to the FDA on Medication guideline distribution and the REMS program, drug shortages. Labor-Health and Human Services appropriations, fiscal year 2010 and 2011; support for Administration's request for FDA funding. Contacts concerning funding for section 3503 of Affordable Care Act (P.L. 111-148). Communication to the Office of the National Coordinator for Health Information Technology regarding its strategic plan. Communication to Office of Management and Budget concerning consumer medication information.
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS via AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
2011 · first_quarter · Q1
Communication to Surgeon General on recognition of pharmacists as health care providers.
Communication with Centers for Medicare and Medicaid Services regarding administration of medication to inpatients within 30 minutes of scheduled dosage time. Communication with CMS regarding Accountable Care Organizations and the Shared Savings Program, Value Based Purchasing Program, and Innovation Center. S. 274, Medication Therapy Management Empowerment Act, all provisions.
S. 296, Preserving Access to Life-Saving Medications Act, all provisions. Contacts concerning Food and Drug Admnistration (FDA)authority to manage drug shortages. Communication to Office of the National Coordinator for Health Information Technology regarding meaningful use implementation. Labor-Health and Human Services Appropriations, fiscal year 2010 and 2011; support for Administration's request for FDA funding. Contacts concerning funding for section 3503 of Affordable Care Act (PL 111-148). Communication to repeal IRS form 1099 reporting provision in Affordable Care Act. S. 48, Pharmacist Student Loan Repayment Eligibility Act, all provisions.
Comments to the Health Resources and Services Administration on the 340B Drug Discount Program and the procurement of orphan drugs under the program. Submitted letter of support for H.R. 2674, the 340B Improvement Act of 2011.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Communication with Centers for Medicare and Medicaid Services regarding administration of medication to inpatients within 30 minutes of scheduled dosage time. Communication with CMS regarding Accountable Care Orgaizations and the Shared Savings Program, Value Based Purchasing Program, Innovation Center, and hospital inpatient prospective payment system.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE